European Archives - Page 287 of 1058 - European Medical Journal

ESMO 2023 Abstract Highlights

FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…

Improving Inclusivity and Diversity in Clinical Trials

Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…

Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer

Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…

Spotlight: November 2023

GOLD looks back at some of the top pharma news stories of the past month including new appointments, regulatory wins and surprising survey results.

Impact of In-House PCR Testing for Candida auris on Hospital-Onset Cases

Testing for Candida auris on patient admission helped to identify more cases, and reduced the number of hospital-onset cases, according to a new study. Read more.

Patients with HIV at Risk for Mental Health Disorders

According to research, people with an HIV diagnosis are more likely to develop a mental health disorder, such as anxiety and depression. Patients who are not receiving treatment for HIV were at an even higher risk.

Results of the ATLANTIS Trial: A Randomised Controlled Trial of Amitriptyline as Second-Line Treatment for IBS in Primary Care

This webinar explores the ATLANTIS trial, a randomised controlled trial investigating amitriptyline as second-line treatment for irritable…

White Bagging Biosimilars: Navigating Access Challenges in Healthcare

At this year’s American College of Rheumatology (ACR) 2023 Convergence, held in San Diego, California, USA, between 10th–15th…

Food Insecurity Among Patients with Cancer

This paper explores the overlooked influence of food insecurity on cancer care, its correlation with malnutrition and poor patient…

Atypical Presentations of Hand, Foot, and Mouth Disease

A new study suggests identification of atypical cutaneous manifestations of hand, foot, and mouth disease (HFMD), such as atypical distribution of vesicles, could improve patient care.